Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13). (Q37741989)
Jump to navigation
Jump to search
scientific article published on 31 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13). |
scientific article published on 31 March 2017 |
Statements
1 reference
Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13). (English)
1 reference
Undine E Lang
1 reference
Andrei-Nicolae Vasilescu
1 reference
Nina Schweinfurth
1 reference
Peter Gass
1 reference
Dragos Inta
1 reference
Sarah Eckart
1 reference
31 March 2017
1 reference
1 reference
973-980
1 reference
Identifiers
1 reference
1 reference
1 reference